Myriad Genetics reported $201.4M in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Agilent A:US USD 1.38B 71M
Becton, Dickinson and BDX:US USD 4B 293M
Bio Rad Laboratories BIO:US USD 588M 17.12M
Biocept BIOC:US USD 11.16M 4.54M
Bruker BRKR:US USD 507.6M 6.9M
Danaher DHR:US USD 6.07B 425M
Exact Sciences EXAS:US USD 661.13M 20.09M
Fluidigm FLDM:US USD 54.67M 2.67M
Hologic HOLX:US USD 811.8M 500K
Illumina ILMN:US USD 4.77B 3.03B
Johnson & Johnson JNJ:US USD 19.51B 1.54B
Mettler Toledo International MTD:US USD 709.96M 11.73M
Myriad Genetics MYGN:US USD 201.4M 4.3M
Nanostring Technologies NSTG:US USD 64.48M 4.83M
Orasure Technologies OSUR:US USD 115.59M 14.07M
Perkinelmer PKI:US USD 601.02M 377.69M
Quest Diagnostics DGX:US USD 2.2B 104M
Repligen RGEN:US USD 148.08M 3.61M
Thermo Fisher Scientific TMO:US USD 9.59B 622M
Veracyte VCYT:US USD 85.27M 1.67M
Waters WAT:US USD 516.54M 1.86M